EMEA-003031-PIP01-21 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Ophthalmology
PIP number: P/0448/2021
Route(s) of administration: Ocular use
Pharmaceutical form(s):
Eye drops, solution
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001545-PIP01-13-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0065/2020
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Powder and solvent for suspension for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
EMEA-001888-PIP01-15-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0429/2020
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Powder and solvent for solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Dexamethasone Taw
dexamethasone phosphate
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
EMEA-002375-PIP02-18 - paediatric investigation plan
Decision type: RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
Therapeutic area: Oto-rhino-laryngology
PIP number: P/0242/2019
Route(s) of administration: Auricular use
Pharmaceutical form(s):
Ear drops, solution
Decision date:
Last updated:
Compliance check: ✖
PIPHuman